Radiological Society of North America (RSNA)

The Radiological Society of North America (RSNA) is a non-profit organization that represents 31 radiologic subspecialties from 145 countries around the world. We provide high-quality educational resources, including continuing education credits toward physicians’ certification maintenance, host the world’s largest radiology conference and publish five top peer-reviewed journals.

PHOTO GALLERY: Medical imaging technology at RSNA 2024

Take a virtual tour around the Radiological Society of North America (RSNA) meeting to see the sights and new technologies displayed across the vast exhibit hall floors.

 RBMA Board member Kit Crancer outlines the key legislation in radiology to watch.

Pending radiology bills in Congress and predicting the Trump administration's impact on imaging

Kit Crancer, RBMA board member, speaks with Radiology Business about key legislative developments on the Hill that will affect the specialty. 

RSNA Board member Richard Heller, MD, explains issues with Medicare reinburements and the No Surprises Act and Congressional actions that may fix both.

Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

RSNA attendees through bore of the new release Philips CT 5300 scanner at RSNA 2024. Three new CT systems were released at RSNA that included numerous AI enhancements. Photo by Dave Fornell. #RSNA #RSNA24 #RSNA2024

Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Key trends in enterprise imaging

Radiology is going though a period of disruption with a growing radiologist shortage, decreasing reimbursements and increasing numbers of exams, making workflow efficiency a critical concern.

Seetharam (Ram) Chadalavada, MD, MS, Vice Chair of Radiology – Informatics, University of Cincinnati, UC Health, Associate Professor of Radiology Surgery, and Director of Interventional Radiology Medical Student Education, explains considerations radiology trainees should think about when they negotiate an employment contract.

Key points of contract negotiations for radiology trainees

Rads should learn more about employment negotiations before signing a contract, says Seetharam Chadalavada, MD, vice chair of radiology informatics at the University of Cincinnati.

Medical 3D printing expert Summer Decker, PhD, professor and vice chair for research and innovation, and director of 3D clinical applications, University of South Florida (USF) Morsani College of Medicine and Tampa General Hospital, explains what is involved in creating a 3D printiung program in radiology and how it helps patient care.

Pitching the business case for 3D printing labs in radiology

Medical 3D printing expert Summer Decker, PhD, University of South Florida, explains how her lab has helped improve patient care. 

Kate Hanneman, MD, University Of Toronto, explains why vendors and hospitals are increasingly discussing lowing their carbon footprint by starting with radiology. 

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.